By Professor Sallie Pearson

Journal articles

Varney B; Zoega H; Gillies MB; Brett J; Pearson SA; Havard A, 2022, 'Prescription opioid use in Australian women of reproductive age: Implications for unplanned pregnancies', British Journal of Clinical Pharmacology, 88, pp. 1298 - 1320, http://dx.doi.org/10.1111/bcp.15074

Daniels B; Schaffer A; Buckley NA; Bruno C; Jun M; Pearson SA; Zoega H, 2022, 'The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis', Pharmacoepidemiology and Drug Safety, 31, pp. 370 - 378, http://dx.doi.org/10.1002/pds.5395

Sotade OT; Pearson SA; Jorm LR; Kushwaha VV; Sedrakyan A; Falster MO, 2022, 'Changing Practice: Procedural Volume of Transcatheter Aortic Valve Implantation by Age and Funding in New South Wales, 2002–2018', Heart Lung and Circulation, 31, pp. e17 - e19, http://dx.doi.org/10.1016/j.hlc.2021.09.010

Lord SJ; Bahlmann K; O'Connell DL; Kiely BE; Daniels B; Pearson SA; Beith J; Bulsara MK; Houssami N, 2022, 'De novo and recurrent metastatic breast cancer – A systematic review of population-level changes in survival since 1995', Eclinicalmedicine, 44, http://dx.doi.org/10.1016/j.eclinm.2022.101282

Falster MO; Schaffer AL; Wilson A; Nasis A; Jorm LR; Hay M; Leeb K; Pearson SA; Brieger D, 2022, 'Evidence-practice gaps in P2Y12 inhibitor use after hospitalisation for acute myocardial infarction: findings from a new population-level data linkage in Australia', Internal Medicine Journal, 52, pp. 249 - 258, http://dx.doi.org/10.1111/imj.15036

Rahman S; Trussell A; Pearson SA; Buckley NA; Karanges EA; Cairns R; Litchfield M; Todd A; Gisev N, 2022, 'Trends in transdermal fentanyl utilisation and fatal fentanyl overdose across Australia (2003–2015)', Drug and Alcohol Review, 41, pp. 435 - 443, http://dx.doi.org/10.1111/dar.13391

Hong S; Daniels B; van Leeuwen MT; Pearson SA; Vajdic CM, 2022, 'Incidence and risk factors of hypertension therapy in Australian cancer patients treated with vascular signalling pathway inhibitors', Discover Oncology, 13, pp. 6, http://dx.doi.org/10.1007/s12672-022-00468-3

de Oliveira Costa J; Gillies MB; Schaffer AL; Peiris D; Zoega H; Pearson SA, 2022, 'Changes in antidepressant use in Australia: A nationwide analysis (2015–2021)', Australian and New Zealand Journal of Psychiatry, 57, http://dx.doi.org/10.1177/00048674221079740

Elliott MJ; Amir E; Pearson SA; Barton MB; Wilson BE, 2022, 'Prioritising access to cancer drugs', The Lancet Oncology, 23, pp. e1 - e1, http://dx.doi.org/10.1016/S1470-2045(21)00641-0

Wilson BE; Elliott MJ; Pearson SA; Amir E; Barton MB, 2022, 'Resource stratified guidelines for cancer: Are they all the same? Interguideline concordance for systemic treatment recommendations', International Journal of Cancer, 150, pp. 91 - 99, http://dx.doi.org/10.1002/ijc.33764

Schaffer AL; Chia J; Brett J; Pearson S; Falster MO, 2022, 'A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia', Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 42, pp. 828 - 836, http://dx.doi.org/10.1002/phar.2735

De Oliveira Costa J; Pearson SA; Elshaug AG; Van Gool K; Jorm LR; Falster MO, 2021, 'Rates of Low-Value Service in Australian Public Hospitals and the Association with Patient Insurance Status', JAMA Network Open, 4, pp. e2138543, http://dx.doi.org/10.1001/jamanetworkopen.2021.38543

Liu Y; Chu H; Peng K; Yin X; Huang L; Wu Y; Pearson SA; Li N; Elliott P; Yan LL; Labarthe DR; Hao Z; Feng X; Zhang J; Zhang Y; Zhang R; Zhou B; Li Z; Sun J; Zhao Y; Yu Y; Tian M; Neal B; Liu H, 2021, 'Factors Associated with the Use of a Salt Substitute in Rural China', JAMA Network Open, 4, pp. e2137745, http://dx.doi.org/10.1001/jamanetworkopen.2021.37745

Pearson SA; Pratt N; Costa JDO; Zoega H; Laba TL; Etherton-Beer C; Sanfilippo FM; Morgan A; Ellett LK; Bruno C; Kelty E; Ijzerman M; Preen DB; Vajdic CM; Henry D; de Oliveira Costa J, 2021, 'Generating real-world evidence on the quality use, benefits and safety of medicines in australia: History, challenges and a roadmap for the future', International Journal of Environmental Research and Public Health, 18, pp. 13345, http://dx.doi.org/10.3390/ijerph182413345

Schaffer AL; Dobbins TA; Pearson SA, 2021, 'Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions', BMC Medical Research Methodology, 21, pp. 58, http://dx.doi.org/10.1186/s12874-021-01235-8

Havard A; Choi SKY; Pearson SA; Chow CK; Tran DT; Filion KB, 2021, 'Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia', JAMA Network Open, 4, pp. E2136372, http://dx.doi.org/10.1001/jamanetworkopen.2021.36372

Pace J; Ghinea N; Pearson SA; Kerridge I; Lipworth W, 2021, 'Consumer perspectives of accelerated access to medicines: a qualitative study', Journal of Health Organization and Management, 35, pp. 987 - 1007, http://dx.doi.org/10.1108/JHOM-08-2020-0344

Mintzes B; Bhasale A; Torka M; Lopert R; Pearson SA; Lexchin J; Bero L, 2021, 'A sorry tale of unnecessary secrecy about medicine safety', Internal Medicine Journal, 51, pp. 1765 - 1766, http://dx.doi.org/10.1111/imj.15513

Tadrous M; Daniels B; Pearson SA; Gomes T, 2021, 'Comparison of claims from high-drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis', CMAJ Open, 9, pp. E1048 - E1054, http://dx.doi.org/10.9778/cmajo.20200291

de Oliveira Costa J; Bruno C; Baranwal N; Gisev N; Dobbins TA; Degenhardt L; Pearson SA, 2021, 'Variations in Long-term Opioid Therapy Definitions: A Systematic Review of Observational Studies Using Routinely Collected Data (2000-2019)', British Journal of Clinical Pharmacology, 87, pp. 3706 - 3720, http://dx.doi.org/10.1111/bcp.14798

Neal B; Wu Y; Feng X; Zhang R; Zhang Y; Shi J; Zhang J; Tian M; Huang L; Li Z; Yu Y; Zhao Y; Zhou B; Sun J; Liu Y; Yin X; Hao Z; Yu J; Li KC; Zhang X; Duan P; Wang F; Ma B; Shi W; Tanna GLD; Stepien S; Shan S; Pearson SA; Li N; Yan LL; Labarthe D; Elliott P; Di Tanna GL, 2021, 'Effect of Salt Substitution on Cardiovascular Events and Death', New England Journal of Medicine, 385, pp. 1067 - 1077, http://dx.doi.org/10.1056/NEJMoa2105675

Lord S; Daniels B; Kiely B; O'Connell D; Pearson S-A; Beith J; Bulsara M; Houssami N, 2021, '1018Long-term risk of distant metastasis and post-metastasis survival for breast cancer: health record linkage study', International Journal of Epidemiology, 50, http://dx.doi.org/10.1093/ije/dyab168.400

Mathieson S; Wertheimer G; Maher CG; Lin C; McLachlan AJ; Buchbinder R; Pearson S-A; Underwood M, 2021, '288What proportion of patients with chronic noncancer pain are prescribed an opioid medicine?', International Journal of Epidemiology, 50, http://dx.doi.org/10.1093/ije/dyab168.421

Tuesley K; Webb P; Protani M; Spilsbury K; Pearson S-A; Coory MD; Donovan P; Stewart LM; Pandeya N; Jordan S, 2021, '794Bisphosphonate use and risk of ovarian cancer, a nested case-control study using national health data', International Journal of Epidemiology, 50, http://dx.doi.org/10.1093/ije/dyab168.667

Yin X; Tian M; Sun L; Webster J; Trieu K; Huffman MD; Jaime Miranda J; Marklund M; Wu JHY; Cobb LK; Chu H; Pearson SA; Neal B; Liu H, 2021, 'Barriers and facilitators to implementing reduced-sodium salts as a population-level intervention: A qualitative study', Nutrients, 13, pp. 3225, http://dx.doi.org/10.3390/nu13093225

Tang M; Daniels B; Aslam M; Schaffer A; Pearson SA, 2021, 'Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study', Lancet Regional Health Western Pacific, 14, pp. 100226, http://dx.doi.org/10.1016/j.lanwpc.2021.100226

Peng CQ; Lawson KD; Heffernan M; McDonnell G; Liew D; Lybrand S; Pearson SA; Cutler H; Kritharides L; Trieu K; Huynh Q; Usherwood T; Occhipinti JA, 2021, 'Gazing through time and beyond the health sector: Insights from a system dynamics model of cardiovascular disease in Australia', Plos One, 16, http://dx.doi.org/10.1371/journal.pone.0257760

Tang M; Daniels B; Schaffer AL; Pearson SA, 2021, 'Real-world data to advance HER2-targeted cancer medicines research: Playing to the strengths of clinical registry and administrative data', Asia Pacific Journal of Clinical Oncology, 17, pp. 414 - 415, http://dx.doi.org/10.1111/ajco.13554

Daniels B; Kiely BE; Tang M; Houssami N; Lord SJ; Pearson SA, 2021, 'Trastuzumab emtansine for HER2-positive metastatic breast cancer: Outcomes from a whole-of-population Australian cohort', Breast, 58, pp. 106 - 112, http://dx.doi.org/10.1016/j.breast.2021.05.001

Tang M; Pearson SA; Schaffer AL; Lewis CR; John T; Simes RJ; Lee CK, 2021, 'Are clinical trial eligibility criteria representative of older patients with lung cancer? A population-based data linkage study', Journal of Geriatric Oncology, 12, pp. 930 - 936, http://dx.doi.org/10.1016/j.jgo.2021.02.003

Tang M; Schaffer AL; Kiely BE; Daniels B; Lee CK; Simes RJ; Pearson SA, 2021, 'Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based study', Breast Cancer Research and Treatment, 187, pp. 893 - 902, http://dx.doi.org/10.1007/s10549-021-06135-5

Huang L; Yu J; Neal B; Liu Y; Yin X; Hao Z; Wu Y; Yan LL; Wu JHY; Joshi R; Shi J; Feng X; Zhang J; Zhang Y; Zhang R; Zhou B; Li Z; Sun J; Zhao Y; Yu Y; Pearson SA; Chen Z; Tian M, 2021, 'Feasibility and validity of using death surveillance data and SmartVA for fact and cause of death in clinical trials in rural China: A substudy of the China salt substitute and stroke study (SSaSS)', Journal of Epidemiology and Community Health, 75, pp. 540 - 549, http://dx.doi.org/10.1136/jech-2020-214063

De Oliveira Costa J; Bruno C; Schaffer AL; Raichand S; Karanges EA; Pearson SA, 2021, 'The changing face of Australian data reforms: Impact on pharmacoepidemiology research', International Journal of Population Data Science, 6, pp. 1418, http://dx.doi.org/10.23889/ijpds.v6i1.1418

Pace J; Kerridge I; Pearson S; Lipworth W, 2021, 'Physicians' attitudes towards accelerated access to medicines', Health Economics Policy and Law, 16, pp. 154 - 169, http://dx.doi.org/10.1017/S1744133119000288

Brett J; Pearson SA; Daniels B; Wylie CE; Buckley NA, 2021, 'A cross sectional study of psychotropic medicine use in Australia in 2018: A focus on polypharmacy', British Journal of Clinical Pharmacology, 87, pp. 1369 - 1377, http://dx.doi.org/10.1111/bcp.14527

Ghinea N; Critchley C; Morrell B; Kerridge I; Campbell T; Day R; Gazarian M; Isaacs D; Liauw W; Olver I; Pace J; Pearson S; Salkeld G; Lipworth W, 2021, 'A survey of Australian public attitudes towards funding of high cost cancer medicines', Health Policy, 125, pp. 327 - 334, http://dx.doi.org/10.1016/j.healthpol.2020.12.002

Falster MO; Charrier R; Pearson SA; Buckley NA; Daniels B, 2021, 'Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia', British Journal of Clinical Pharmacology, 87, pp. 1264 - 1274, http://dx.doi.org/10.1111/bcp.14504

Tervonen HE; Schaffer AL; Luckett T; Phillips J; Litchfield M; Todd A; Pearson SA, 2021, 'Patterns of opioid use in older people diagnosed with cancer in New South Wales, Australia', Pharmacoepidemiology and Drug Safety, 30, pp. 360 - 370, http://dx.doi.org/10.1002/pds.5081

Daniels B; Luckett T; Holliday S; Liauw W; Lovell M; Phillips J; Rowett D; John TN; Tervonen H; Pearson SA, 2021, 'Patterns of oxycodone controlled release use in older people with cancer following public subsidy of oxycodone/naloxone formulations: An Australian population-based study', Asia Pacific Journal of Clinical Oncology, 17, pp. 68 - 78, http://dx.doi.org/10.1111/ajco.13408

Wertheimer G; Mathieson S; Maher CG; Lin CWC; McLachlan AJ; Buchbinder R; Pearson SA; Underwood M, 2021, 'The Prevalence of Opioid Analgesic Use in People with Chronic Noncancer Pain: Systematic Review and Meta-Analysis of Observational Studies', Pain Medicine United States, 22, pp. 506 - 517, http://dx.doi.org/10.1093/pm/pnaa322

Wilson BE; Jacob S; Do V; Amir E; Bray F; Ferlay J; Knaul FM; Elawawy A; Pearson SA; Barton MB, 2021, 'Are nccn resource-stratified guidelines for breast cancer systemic therapy achievable? a population-based study of global need and economic impact', JCO Global Oncology, 7, pp. 1074 - 1083, http://dx.doi.org/10.1200/GO.21.00028

Daniels B; Pearson SA; Buckley NA; Bruno C; Schaffer A; Zoega H, 2021, 'Coming to grips with seemingly conflicting results in programme evaluation: The devil's in the detail', BMJ Quality and Safety, 30, pp. 70 - 71, http://dx.doi.org/10.1136/bmjqs-2020-012118

Pratt N; Camacho X; Vajdic C; Degenhardt L; Laba TL; Hillen J; Etherton-Beer C; Preen D; Jorm L; Donnolley N; Havard A; Pearson SA, 2021, 'The Medicines Intelligence Centre of Research Excellence: Co-creating real-world evidence to support the evidentiary needs of Australian regulators and payers', International Journal of Population Data Science, 6, http://dx.doi.org/10.23889/IJPDS.V6I3.1726

Yin X; Liu H; Webster J; Trieu K; Huffman MD; Miranda JJ; Marklund M; Wu JHY; Cobb LK; Li KC; Pearson S-A; Neal B; Tian M, 2021, 'Availability, Formulation, Labeling, and Price of Low-sodium Salt Worldwide: Environmental Scan', JMIR Public Health and Surveillance, 7, pp. e27423, http://dx.doi.org/10.2196/27423

Vogel JP; Tendal B; Giles M; Whitehead C; Burton W; Chakraborty S; Cheyne S; Downton T; Fraile Navarro D; Gleeson G; Gordon A; Hunt J; Kitschke J; McDonald S; McDonnell N; Middleton P; Millard T; Murano M; Oats J; Tate R; White H; Elliott J; Roach V; Homer CSE; McGowan S; Ballenden N; Barrett TL; Beavis V; Saunders JB; Buchanan T; Buchanan-Grey M; Casey D; Cowie M; Doyle J; Frydenberg M; Gnjidic D; Green S; Greenland R; Griffin K; Groombridge S; Hardy L; Hodak A; Holley A; Jovanovska V; Knight S; Michaels K; Morley P; Morphet J; Nou S; Russo P; Sarson M; Young A; Norris S; Morris-Donovan B; Gurry S; Hudson E; Hurley S; Primmer D; Timms S; Whicker S; Mukherjee S; Agostino J; Booth K; Burr L; Byers L; Cameron P; Cooper M; Cheng A; Fowler P; Glanville A; Leder K; McGloughlin S; McMullan B; McPhee E; Mitchell B; Morgan M; Myles P; O’Donnell C; Parr M; Phillips J; Randall R; Varndell W; Whyte I; William L; Brightwell R; Condon L; Deshpande A; Ehm A; Ferrie M; Muller J; Pullin L; Robinson E; Witt A; Larkins S; Morgan M; Taylor G; Agostino J; Burgess P; Agar M; Peiris D; Pearson S; Matthews G; McCarthy S, 2020, 'Clinical care of pregnant and postpartum women with COVID-19: Living recommendations from the National COVID-19 Clinical Evidence Taskforce', Australian and New Zealand Journal of Obstetrics and Gynaecology, 60, pp. 840 - 851, http://dx.doi.org/10.1111/ajo.13270

Badgery-Parker T; Pearson SA; Elshaug AG, 2020, 'Estimating misclassification error in a binary performance indicator: Case study of low value care in Australian hospitals', BMJ Quality and Safety, 29, pp. 992 - 999, http://dx.doi.org/10.1136/bmjqs-2019-010564

Yin X; Liu H; Trieu K; Webster J; Farrand C; Li KC; Pearson S; Tian M, 2020, 'The effectiveness, feasibility, and acceptability of low-sodium salts worldwide: An environmental scan protocol', Journal of Clinical Hypertension, 22, pp. 2258 - 2265, http://dx.doi.org/10.1111/jch.14054

Sotade OT; Falster M; Girardi LN; Pearson SA; Jorm LR, 2020, 'Age-stratified outcomes of bioprosthetic and mechanical aortic valve replacements in an Australian cohort of 13 377 patients', BMJ Surgery Interventions and Health Technologies, 2, pp. e000036, http://dx.doi.org/10.1136/bmjsit-2020-000036

Daniels B; Pearson SA; Vajdic CM; Pottegård A; Buckley NA; Zoega H, 2020, 'Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: A population-based case-control study', Basic and Clinical Pharmacology and Toxicology, 127, pp. 320 - 328, http://dx.doi.org/10.1111/bcpt.13463

Wylie CE; Daniels B; Brett J; Pearson SA; Buckley NA, 2020, 'A national study on prescribed medicine use in Australia on a typical day', Pharmacoepidemiology and Drug Safety, 29, pp. 1046 - 1053, http://dx.doi.org/10.1002/pds.5093

Back to profile page